Bharat Biotech plans to launch coronavirus vaccine Covaxin

Bharat Biotech, which is developing India's indigenous coronavirus vaccine, is planning to launch the vaccine in the second quarter of 2021 if it gets the approval from regulatory authorities, a company executive told Reuters.

AIIMS Delhi is likely to submit a proposal to its ethics committee on Phase III clinical trials of Covaxin. Bharat Biotech, which has received initial approval from Drugs Controller General of India to conduct late-stage trials for its vaccine candidate Covaxin said it plans to conduct recruitment and dosage for the Phase III trials in November. Watch this video to know more.